Phase II Study of Gemcitabine Plus Oxaliplatin as First-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer
British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6602667
Full Text
Open PDFAbstract
Available in full text
Date
June 14, 2005
Authors
Publisher
Springer Science and Business Media LLC